Solutions...

Pricing & Access
Strategies

Optimal pricing strategies for development decisions and market access.

Read more

Conjoint
Research

Delivering conjoint that can handle the intricacies of the pharma market.

Read more

Forecasting
Software

Allowing leading pharma companies to build evidence-based forecasts fast and easily.

Read more

Launch Sequence
Simulators

Get your country launch sequence right. Capture full value in the face of international reference pricing.

Read more

Training
Courses

Industry-leading pricing-for-market-access and forecasting training.

Read more

About Us

Why leading global pharma companies put their trust in us

Our founder was a country manager and headed global marketing for major pharma companies. But he became exasperated by – and determined to do something about – the lack of evidence behind pharma pricing and forecasting. Many global pharma executives have felt the same way. Now they work with Inpharmation to satisfy their need for properly validated pricing, forecasting, and market research.

We have worked on thousands of projects with all the top global pharma companies. Not only do we provide evidence-based approaches, but we have also learned how to apply them to every therapy area and every healthcare system around the world.
Our colleagues are super-smart and super-dedicated. What makes us proudest of all is that our clients regularly tell us that the project we worked on together was their best yet.

Our team’s deep understanding of the industry allows us to produce top-quality pricing research, market research, and forecasts. And, equally important, to provide the strategic advice that follows from it.

Who are we?

Meet the senior team

Gary Johnson

Gary Johnson

Founder and Executive Chair

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Gary's Bio
Gary is the Founder and Chairman of Inpharmation – a company that provides a host of unique, evidence-based research techniques for pricing, forecasting, and market researching pharmaceuticals.

Gary has worked with all the world’s leading pharma companies. He has a host of awards for his conference papers and his writing. His books on pharmaceutical pricing, forecasting, market research, and the use of AI in these fields are read and referred to by pharma executives around the world.

He has trained thousands of pharma executives how to forecast and price pharmaceuticals.

Prior to founding Inpharmation, Gary held senior positions – including country manager and head of global marketing – in major pharma companies. He has degrees in medicine and management. He is a Sloan Fellow of London Business School and a Fellow of the Royal Society of Medicine.

Karen Dobbs

Karen Dobbs

Vice Chair and Finance Director

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Karen’s Bio
As one of the founders, Karen’s role in Inpharmation has been to build the finance, administration, and HR teams as the company has grown.

Expert in the workings of every department, Karen has been involved in the recruitment of every person employed by Inpharmation.
Her aim is to continue to build fantastic teams by bringing fantastic people into the company.
Karen holds degrees in genetics, microbiology, and management.

Rob Watson

Rob Watson

Director of Programming

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Rob's Bio

Rob met Gary (our founder) at university, where they spent three glorious years studying and touring Nottingham’s clubs and pubs with their rock band.

Early on Rob realized that the future was in computing. For years he ran his own computing company working with the likes of IBM, British Airways, and major banks (JP Morgan, Lloyds, NatWest), investment companies, consultancies, and insurance giants.

In 2000, Gary finally enticed Rob to join Inpharmation as Director of Programming. Excited by the challenge, Rob stressed that he could only stay for a couple of years. And yet, here he is two decades on still bringing his superior programming skills and a vast experience to bear on everything we do.

Rob has a bachelor’s in physics and a postgrad in computing.

Nicholas Taylor

Nicholas Taylor

Director of Modeling and Analytics

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Nicholas' Bio

Nick takes a hands-on approach to running Inpharmation’s modeling and analytics department. He is involved in every project from the beginning, through to delivery, and beyond. It is Nick who decides who in Inpharmation has the best strategic and technical knowledge to lead each project, and then chooses the best people to work within that team. Clients value the fact that Nick knows their projects intimately and is always available to speak to them.

His consulting experience is enormously wide. He has worked with all the top 20 pharma companies and the majority of the top 50. He has worked in all major therapy areas, all major HTA systems, and at all stages of the pharmaceutical lifecycle. He has worked in pricing, market access, demand forecasting, market research, behavior-based pricing, and international reference pricing.

Nick was instrumental in developing Inpharmation’s market leading international referencing software. He was one of the first people to realize, way back in 2008, that financial crises lead to pharmaceutical price cuts which cascade through the international referencing system. He has successfully guided many clients accordingly.

Nick is a sought-after speaker on pricing, market access, and international reference pricing. He delivers forecasting and pricing training courses. He co-authors papers with clients.

Nick has degrees in Molecular and Cellular Biochemistry from the University of Oxford.

He joined Inpharmation’s Board of Directors in 2021.

Kim Robinson

Kim Robinson

Director of Sales and Marketing

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Kim’s Bio
Kim believes that successful collaborations begin with a strong understanding of our clients’ needs and what they are ultimately trying to achieve. The key, he believes, is listening carefully, asking the right questions, building a picture. Only then can we find the right and most elegant solutions to help them. This is one of the reasons our customers choose to work with us again and again.

Over the past decade Kim has built a talented and hard-working business development team which is underpinned by his philosophy of listening to the client.

Kim is hugely experienced. He helps our customers in all areas of pharmaceutical pricing, forecasting, and market research. He has worked with most of the top 50 pharma companies across the globe and has experience in all major therapy areas and across all stages of the pharmaceutical lifecycle.

Kim has a First-Class Honours degree in Biomedical Sciences from the University of Manchester.

He joined Inpharmation’s Board of Directors in 2021.

Sam Johnson

Sam Johnson

Director of Research and Development

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Sam's Bio
Sam joined Inpharmation in 2010 as a financial analyst but was quickly persuaded to transfer his modeling talents to pharmaceuticals. He has been promoted several times, joining the Inpharmation Board in 2021.

As Director of Research and Development, Sam has developed many of Inpharmation’s predictive tools including machine learning algorithms, econometric methods, and conjoint software. An important part of his work is predicting changes in the pharma environment and finding ways to effectively model these for our clients – he has some exciting developments in the pipeline.

Sam runs major research projects for clients in all major therapy areas, all stages of product development, all major HTA systems, and all types of pharmaceuticals – from small molecules to monoclonals and cell and gene therapies.

Sam trains pharma companies across the world on how to forecast and price pharmaceuticals. He is a regular presenter at Europe’s leading pharma training forum: The Centre for Executive Leadership for Pharmaceuticals. Sam also co-authors papers with clients.

Sam has a first-class degree in economics from the University of Manchester.

Harry Bennett

Harry Bennett

Business Development Manager

For Harry, communication is the key to successful collaboration. He takes the time to properly understand his client’s needs before proposing solutions that will deliver on their objectives. Once there is agreement, it is Harry who helps pull together the best Inpharmation team to work on the project.

Harry has experience in pricing, forecasting, and demand research, across all major therapy areas and all stages of product development. He works with companies of all sizes from top 20 global pharma to niche biotechs.

He has a first-class bachelor’s degree in Medical Engineering and a master’s, with merit, in Nanomedicine from Swansea University.

Mark Richer

Mark Richer

Business Development Manager

Before joining Inpharmation, Mark developed his commercial acumen working in early-drug discovery at GlaxoSmithKline.

Mark’s strong background in pharmaceuticals is invaluable in his role with Inpharmation. Often the first point of contact with clients, Mark focuses on understanding exactly what his clients are trying to achieve and then works with them to find the best solution. He has helped clients with products in all the major therapy areas and at all stages of the product lifecycle.

Mark prides himself in exceeding customer expectations, and has a master’s in pharmacology from the University of Aberdeen.

James Macalester

James Macalester

Business Development Manager

Collaboration is at the heart of everything James does. He leads focused conversations to gain an in-depth understanding of a client’s needs and the specific challenges they face. From this foundation, he works with the client to formulate the optimal strategy to accomplish their goals.

James is experienced in scoping research projects across pricing, forecasting, and demand research. He has worked across all major therapy areas and stages of product development.

James has a bachelor’s degree in Biochemistry from the University of Bath.

Matt Rofe

Matt Rofe

Senior Business Development Consultant

Matt believes collaboration is key to a good outcome. His approach is to work closely with his customers to understand and map out their challenges. Once he is sure he has the full picture, Matt proposes customized solutions that he is confident will provide his clients with the answers they need. This approach has resulted in lasting collaborative partnerships which help his clients make optimal business decisions.

Matt is experienced in all Inpharmation’s core areas of expertise: pricing, forecasting, and demand research. He has advised in all major therapy areas and all stages of the pharmaceutical lifecycle.

Matt graduated from the University of Birmingham with a bachelor’s degree in Biological Sciences.

Harshni Chandaria

Harshni Chandaria

Principal Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Harshni 's Bio
Harshni has extensive experience leading pricing, reimbursement and market access, demand forecasting, market research, and international reference pricing projects. She has worked with most of the top 20 pharma companies and many of the top 50.  She has delivered projects in all major therapy areas, at all stages of the pharmaceutical lifecycle, and in all major HTA systems.

Harshni is known for delivering high-quality projects to tight deadlines. Successful projects depend on liaising closely with customers from the outset and ensuring everyone on the team understands the brief – and then making sure everyone keeps communicating. This is Harshni’s forte.

She is a natural problem solver and comes up with some very elegant research and modeling solutions.

Harshni has a master’s in Chemistry with Medicinal Chemistry from Imperial College London.

Blythe Silve

Blythe Silve

Principal Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Blythe’s Bio
Blythe has consulted for many of the top 20 and top 50 pharma companies. She is experienced in pricing, reimbursement and market access, demand forecasting, market research, and international reference pricing projects.

In addition to her modeling and analytical skills, Blythe is responsible for the day-to-day management of projects. This requires a blend of problem solving, operations management, liaising, and coordinating to keep everyone informed and on track. In projects with built-in decision points, it is Blythe’s job to explore all the options with our clients to help them make the best possible decisions. She has a strong track record of finding ways to make things more efficient and our customers’ lives easier.

Blythe has extensive experience delivering projects to clients and training them to use our programs, models, and market simulators. She has co-authored papers with abstracts presented at ISPOR.

She has a master’s in Chemistry for Drug Discovery from the University of Bath.

Adam Joyce

Adam Joyce

Principal Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Adam's Bio
Adam brings together modeling skills with a strong background in macro- and micro-economics, plus a deep understanding of the pharmaceutical arena. He is known for his skill at producing robust and insightful market strategies.

Adam has exceptional knowledge of the international pricing systems. He heads the team which sources pricing mechanisms across the world and is responsible for keeping Inpharmation’s data and models up-to-the-minute accurate.

He has worked with many of the top 50 pharma companies on pricing, reimbursement, and market access strategies. Highly numerate and insightful, he has an eye for seeing how projects can be run more efficiently.

An excellent communicator, he also runs training programs for pharma executives.

Adam has a master’s in Economics from the University of Sheffield where he also received the award for the best student in the year.

Rickie Zhang

Rickie Zhang

Principal Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Rickie's Bio
Rickie is known for his modeling expertise and his eye for detail. He leads the team responsible for developing our innovative contracting simulators. This requires in-depth knowledge of the latest trends and the ability to build these into user-friendly, customized models.

Clients ask to work with Rickie because they know he will deliver an excellent project on time. They like his calm approach and that he keeps them fully informed at every stage. When they have important decisions to make, Rickie is particularly good at exploring options with them.

Rickie has a wealth of experience. He has worked with many of the top 50 pharmaceutical companies across all the major therapy areas. He has led projects in pricing, demand forecasting, market access, international reference pricing, and value-based agreements.

Rickie has a degree in Chemistry from Imperial College London.

Emma Findlater

Emma Findlater

Principal Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Emma’s Bio
Emma’s consulting experience has made her an expert in market research. She also is the international reference pricing technical point-of-contact for many clients and is a clear communicator, able to easily identify and resolve misunderstandings.

Emma is the head of Inpharmation’s internal stakeholder mapping team due to her skill of identifying the right respondents for a project; she leads major projects involving payers, patients, doctors etc. across the world, and works across all major therapy areas.
Emma makes the process of market research easy and accurate by expertly identifying what data is required, formulating clear and unbiased market research questions, and interpreting the results coherently. She has a wealth of knowledge surrounding the major causes of error in pharma market research and knows how to avoid them.

Emma holds a master’s degree in Molecular and Cellular Biochemistry from the University of Oxford.

Nigel Ma

Nigel Ma

Senior Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Nigel's Bio
Nigel has delivered top-quality projects for some very high-profile products. He brings a proactive approach and attention to detail to everything he does. His clients value the time he takes to understand what they are trying to achieve before he crafts solutions for them.

Nigel has worked across all major therapy areas for some of the biggest pharma companies as well as smaller biotechs. He is experienced in pricing, reimbursement and market access, demand forecasting, market research, and international reference pricing.

Internally, Nigel leads the team responsible for developing and updating Inpharmation’s cutting-edge Behavior-Based Pricing tool. This is a pivotal role in the company.

Nigel has a degree in Natural Sciences from Durham University.

Charlotte Brazier

Charlotte Brazier

Senior Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Charlotte's Bio

Charlotte has built a reputation for delivering top-quality projects. She is the training and technical point of contact for many clients who rely on our international reference pricing simulators. Internally, she is responsible for updating our market research simulator which is a key deliverable for our pricing and demand market-research projects.

Charlotte has worked across all major therapy areas and has consulted for many of the top 50 pharma companies. She is experienced in pricing, reimbursement and market access, demand forecasting, and market research.

She has a degree in Biomedical Engineering from Imperial College London.

Morgan Stucki

Morgan Stucki

Senior Consultant

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Morgan’s Bio
Morgan is known for her attention to detail and excellent communication skills. She exceeds clients’ expectations and ensures smooth deliveries by engaging with each of the stakeholders throughout their project.

Morgan has worked across all major therapy areas and consulted for many of the top 20 pharma companies as well as smaller biotechs. She is experienced in pricing, reimbursement and market access, demand forecasting, market research, and international reference pricing projects.

Morgan is heavily involved in training customers to use our programs, models, and simulators. Clients value her ability to read the room and adapt her approach so that every participant gets the most from the training.

Morgan has a degree in Biochemistry from the University of Manchester.

We tailor our services to your exact requirements

Get in touch with us and arrange a meeting

Request a book sample chapter

Image of Inpharmation book covers